Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
medical treatments
![Pfizer’s Covid Boost Crashes to Earth](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Pfizers-Covid-Boost-Crashes-to-Earth-400x400.jpeg)
Pfizer’s Covid Boost Crashes to Earth
- By nasdaqpicks.com
- . 6 August 2023
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
![Big Pharma Bets Big on China](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Big-Pharma-Bets-Big-on-China-400x400.jpeg)
Big Pharma Bets Big on China
- By nasdaqpicks.com
- . 23 July 2023
China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link
![Silicon Valley Money Men Are Buzzing About Robert F. Kennedy Jr.](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Silicon-Valley-Money-Men-Are-Buzzing-About-Robert-F-Kennedy-400x400.jpeg)
Silicon Valley Money Men Are Buzzing About Robert F. Kennedy Jr.
- By nasdaqpicks.com
- . 18 July 2023
Twitter co-founder Jack Dorsey and others are praising the antiestablishment candidate, who is running for the Democratic Party’s presidential nomination. Source link
![FDA Approves First Over-the-Counter Birth-Control Pill](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/FDA-Approves-First-Over-the-Counter-Birth-Control-Pill-400x400.jpeg)
FDA Approves First Over-the-Counter Birth-Control Pill
- By nasdaqpicks.com
- . 13 July 2023
The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly expanding access to contraception among women across the U.S. Source link
![Obesity Drugs Won't Starve These Other Potential Blockbusters](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Obesity-Drugs-Won039t-Starve-These-Other-Potential-Blockbusters-400x400.jpeg)
Obesity Drugs Won't Starve These Other Potential Blockbusters
- By nasdaqpicks.com
- . 7 July 2023
Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were published last week. Source link
![FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/FDA-Approves-Leqembi-Extending-Alzheimer039s-Treatment-to-More-Patients-400x400.jpeg)
FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients
- By nasdaqpicks.com
- . 7 July 2023
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
![Kidney-Care Specialist Diaverum Expected to Be Sold in $2 Billion Deal](http://www.nasdaqpicks.com/wp-content/uploads/2023/04/Kidney-Care-Specialist-Diaverum-Expected-to-Be-Sold-in-2-Billion-400x400.jpeg)
Kidney-Care Specialist Diaverum Expected to Be Sold in $2 Billion Deal
- By nasdaqpicks.com
- . 19 April 2023
Mubadala-backed M42 would buy the operator of 440 dialysis clinics from buyout firm Bridgepoint. Source link
![Moderna, Merck Show Progress Toward Cancer Vaccines](http://www.nasdaqpicks.com/wp-content/uploads/2023/04/Moderna-Merck-Show-Progress-Toward-Cancer-Vaccines-400x400.jpeg)
Moderna, Merck Show Progress Toward Cancer Vaccines
- By nasdaqpicks.com
- . 17 April 2023
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
![Merck in Late-Stage Talks to Acquire Prometheus Biosciences](http://www.nasdaqpicks.com/wp-content/uploads/2023/04/Merck-in-Late-Stage-Talks-to-Acquire-Prometheus-Biosciences-400x400.jpeg)
Merck in Late-Stage Talks to Acquire Prometheus Biosciences
- By nasdaqpicks.com
- . 16 April 2023
Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the
![The 'King Kong' of Weight-Loss Drugs Is Coming](http://www.nasdaqpicks.com/wp-content/uploads/2023/04/The-039King-Kong039-of-Weight-Loss-Drugs-Is-Coming-400x400.jpeg)
The 'King Kong' of Weight-Loss Drugs Is Coming
- By nasdaqpicks.com
- . 3 April 2023
Eli Lilly’s Mounjaro could outpace Ozempic as the most powerful treatment on the market. To develop it, the drug company needed to overhaul long-held but